Clinical Trials Browser

OTHER × Pancreatic Neoplasms × Gastrointestinal × Clear all

NCT04674267 2026-03-18

REACH

Phase NA Recruiting

Gastrointestinal

Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

NCT07470268 2026-03-18

HY-PANC

Phase NA Not yet recruiting

Gastrointestinal

Motor Activity, Pancreatic Neoplasms

NCT06141031 2026-03-17

Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma

Phase 1 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT06893276 2026-03-17

e-Health Psychosocial Stress and Symptom Management (ePSMI) for Pancreatic Cancer Patients

Phase NA Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07477418 2026-03-17

PRISM-TAMP

Phase 1/2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07478185 2026-03-17

Prehab for Pancreatic Cancer Surgery

Phase NA Not yet recruiting

Gastrointestinal

Pancreatic cancer, adult, Pancreatic Neoplasms

NCT06756074 2026-03-16

Reinforced Pancreaticojejunostomy With or Without glubran2

Phase 2 Recruiting

Gastrointestinal

Pancreatic Fistula, Pancreatic Neoplasms

NCT02648282 2026-03-13

Study With CY, Pembrolizumab, GVAX Pancreas Vaccine, and SBRT in Patients With Locally Advanced Pancreatic Cancer

Phase 2 Completed

58 enrolled 9 charts

Gastrointestinal

Pancreatic Neoplasms

NCT06479239 2026-03-13

Panc 002

Phase 1/2 Recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT06712797 2026-03-13

PANTHER-PIC

Phase NA Active not recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07469956 2026-03-13

Surufatinib Plus mFOLFIRINOX and PD-1 Inhibitor as the Neoadjuvant Therapy for High-risk or Borderline Resectable Pancreatic Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07457541 2026-03-12

Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPI

Phase 1 Active not recruiting

BreastGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Colorectal Neoplasms

NCT03875820 2026-03-10

FRAME

Phase 1 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms, Carcinoma, Endometrioid

NCT04194268 2026-03-10

PACK

Phase NA Completed

Gastrointestinal

Pancreatic Neoplasms

NCT06151223 2026-03-10

A Prospective Registry for Patients at High-Risk for Pancreatic Cancer

Gastrointestinal

Pancreatic Neoplasms

NCT06643715 2026-03-10

Research of the Application of Pancreatic Cancer Screening Artificial Intelligence Model "PANDAPro"

Phase NA Recruiting

100,000 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT05162846 2026-03-09

MiGHT

Phase NA Completed

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT05677048 2026-03-09

Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention

Phase NA Active not recruiting

BreastGastrointestinalGynecologic

Breast Neoplasms, Colonic Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Ovarian Neoplasms, Pancreatic Neoplasms, Uterine Neoplasms, Endometrial Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

NCT02047474 2026-03-06

Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer

Phase 2 Completed

46 enrolled 15 charts

Gastrointestinal

Pancreatic Neoplasms

NCT04705818 2026-03-06

CAIRE

Phase 2 Completed

GastrointestinalSarcoma

Tertiary Lymphoid Structures, Pancreatic Neoplasms, Sarcoma, Colorectal Neoplasms

NCT06184867 2026-03-06

CATALYST

Phase NA Completed

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT07254091 2026-03-06

Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic Cancer

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT00899626 2026-03-05

Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients

GastrointestinalOther neoplasm

Colonic Neoplasms, Esophageal Neoplasms, Pancreatic Neoplasms, Precancerous Conditions, Stomach Neoplasms, Colorectal Neoplasms, Adenomatous Polyps

NCT03582189 2026-03-05

MR Guidance for Liver and Pancreas

Gastrointestinal

Liver Neoplasms, Pancreatic Neoplasms

NCT04075305 2026-03-05

MOMENTUM

BreastCNSGastrointestinalGenitourinaryHead & NeckThoracic

Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Genital Neoplasms, Female, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Radiation Injuries, Rectal Neoplasms

NCT04683315 2026-03-05

PANCREAS

Phase 2 Recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT05052671 2026-03-05

OU-SCC-ctDNA

Gastrointestinal

Pancreatic Neoplasms

NCT07189195 2026-03-05

TR-002 for the Treatment of Advanced, Unresectable or Metastatic Solid Tumors and Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma

Phase 1 Recruiting

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

NCT04091295 2026-03-04

BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast

BreastGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Chordoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Osteosarcoma, Neurofibrosarcoma

NCT05065801 2026-03-04

GABRINOX2

Phase 2 Recruiting

Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT06651580 2026-03-04

Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study

Gastrointestinal

Pancreatic Neoplasms, Pancreatitis, Pancreatitis, Chronic

NCT07448376 2026-03-04

EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases

Not yet recruiting

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms, Recurrence

NCT04975516 2026-03-03

Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer

Phase 2 Terminated

Gastrointestinal

Pancreatic Neoplasms

NCT07446946 2026-03-03

POlig

68,303 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT04473794 2026-03-02

Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts

Gastrointestinal

Pancreatic Neoplasms

NCT07443761 2026-03-02

PANREG

Active not recruiting

Gastrointestinal

Pancreatic Neoplasms, Pancreatitis, Chronic

NCT01202136 2026-02-27

PCyst

Gastrointestinal

Pancreatic Cyst, Pancreatic Neoplasms

NCT03164486 2026-02-27

First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide

Phase EARLY_PHASE1 Active not recruiting

BreastGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT04005690 2026-02-27

Targeted Pathway Inhibition in Patients With Pancreatic Cancer

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT04485286 2026-02-27

Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury

Phase 2 Recruiting

GastrointestinalThoracic

Radiation Fibrosis Syndrome, Fibrosis, Lung Neoplasms, Pancreatic Neoplasms

NCT04588025 2026-02-27

Disposable Perfusion Phantom for Accurate DCE (Dynamic Contrast Enhanced)-MRI Measurement of Pancreatic Cancer Therapy Response

Phase NA Recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07405099 2026-02-27

Operative Risk After Pancreatic Surgery in Patients With End Stage Renal Disease

Enrolling by invitation

GastrointestinalGenitourinary

Kidney Failure, Chronic, Pancreatic Neoplasms

NCT07436312 2026-02-27

U-TRANS

Phase NA Not yet recruiting

BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Pancreatic Neoplasms

NCT04605913 2026-02-25

Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC

Phase 1/2 Recruiting

Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

NCT05225428 2026-02-25

VERDI

Phase NA Recruiting

BreastDermatologicGastrointestinalGenitourinaryGynecologicSarcoma

Breast Neoplasms, Kidney Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Colorectal Neoplasms

NCT05642962 2026-02-25

Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)

Phase 1/2 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07360119 2026-02-25

Total Pancreatectomy With Islet Autotransplantation (TPIAT) for High-Risk Patients With Pancreatic Tumors

Phase NA Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07433283 2026-02-25

Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor

Phase 1/2 Recruiting

GastrointestinalGynecologicHead & NeckThoracic

Uterine Cervical Neoplasms, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Thyroid Neoplasms, Vulvar Neoplasms, Colorectal Neoplasms

NCT05014776 2026-02-24

Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer

Phase 2 Active not recruiting

17 enrolled 8 charts

Gastrointestinal

Adenocarcinoma, Carcinoma, Pancreatic Neoplasms

NCT05419479 2026-02-24

Switch Maintenance in Pancreatic

Phase 1/2 Suspended

Gastrointestinal

Pancreatic Neoplasms